MERITAGE PHARMA INC — Form D/A
MERITAGE PHARMA INC of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2011-11-16. The offering totals $7.5M, of which $6.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-11-16
- Form: D/A
- Accession: 0001432016-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $7.5M
- Amount sold: $6.5M
- Remaining: $1.0M
- Minimum investment: $1
- Investors: 10
- Date of first sale: 2011-01-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-154484
Issuer
- Name: MERITAGE PHARMA INC
- CIK: 0001432016
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 12481 HIGH BLUFF DRIVE, SAN DIEGO, CA, 92130
- Phone: 858 436-1660
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| James C Blair, Ph.D. | Director | Princeton, NJ |
| Cam L Garner | Director | San Diego, CA |
| Elaine M Phillips, Ph.D. | Director | San Diego, CA |
| Kenneth J Widder, M.D. | Director | San Diego, CA |
| Malcolm R Hill | Executive Officer | San Diego, CA |
| Elaine M Phillips, Ph.D. | Executive Officer | San Diego, CA |
| Adam K Simpson | Executive Officer | Seattle, WA |
Other filings by this issuer (2)
More